Saturday 17 October 2026
Export SGMT’s income statement to Excel — free account
Sagimet Biosciences Inc.
SGMT Healthcare Biotechnology
Sagimet Biosciences Inc.’s revenue for fiscal 2023 (year ended December 2023) was $2.0 million. In the quarter to June 2026, EPS grew 18.8% and free cash flow fell 22.0%, each against the same quarter a year earlier.
8.02
0.15
−1.84%
Follow SGMT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | |
|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | 0.00 | — | — | — | — |
Altman Z-Score |
— | — | 2.50 | — | — | — | — |
P/S ratio |
— | — | 0.00 | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
— | — | 12.53 | — | — | — | — |
P/FCF ratio |
— | — | 0.00 | — | — | — | — |
P/Operating CF |
— | — | (7.87) | — | — | — | — |
P/B ratio |
— | — | 0.61 | — | — | — | — |
Price to Tangible BV |
— | — | 0.61 | — | — | — | — |
EV/Sales |
— | — | 0.00 | — | — | — | — |
EV/EBITDA |
— | — | 1.27 | — | — | — | — |
EV/Operating CF |
— | — | 1.64 | — | — | — | — |
EV/FCF |
— | — | 1.64 | — | — | — | — |
Quick Ratio |
22.18 | 33.96 | 16.78 | 6.13 | 23.25 | 35.97 | 4.92 |
Current Ratio |
22.82 | 34.30 | 17.09 | 6.21 | 23.46 | 35.99 | 5.21 |
Net Debt/EBITDA |
1.98 | 2.72 | 3.08 | 1.03 | 2.39 | 6.07 | 0.70 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.59% | 0.30% | 3.06% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.04 |
Asset Turnover |
0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.89 | 0.93 | 0.85 | 0.80 | 0.89 | 0.92 | 0.74 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
— | — | — | — | — | — | (442.47) |
| (38.20%) | (36.92%) | 58.14% | 17.67% | 16.62% | 8.71% | 0.00% | |
| (36.89%) | (35.46%) | (42.97%) | (66.26%) | (38.19%) | (28.38%) | 0.00% | |
ROIC |
0.00% | (747.17%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(45.86%) | (30.72%) | (30.64%) | (110.85%) | (44.33%) | (16.96%) | (157.46%) |
Average Days of Receivables |
— | — | 0.00 | — | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 988.85% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 648.15% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 249.50% | 0.00% | — | — | — |
Graham Net Nets |
— | — | 1.63 | — | — | — | — |
Graham Number |
— | — | 0.00 | — | — | — | — |
Earnings Yield |
— | — | (50.00%) | — | — | — | — |
Free Cash Flow Yield |
— | — | (42.63%) | — | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(1.41) | (1.35) | (2.27) | (132.67) | (1.02) | (0.49) | (0.49) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(1.41) | (1.35) | (2.27) | (132.67) | (1.02) | (0.49) | (0.49) |
Cash per Share |
3.50 | 4.82 | 9.07 | 175.22 | 2.65 | 3.21 | 0.48 |
Shareholders Equity per Share |
3.44 | 4.97 | 8.71 | (1,012.73) | 2.64 | 3.13 | 0.41 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.44 | 4.97 | 8.71 | (1,012.73) | 2.64 | 3.13 | 0.41 |
Free Cash Flow |
(45.65) | (42.43) | (23.77) | (24.49) | (21.71) | (10.42) | (10.55) |
Working Capital |
111.30 | 148.32 | 90.99 | 27.51 | 54.80 | 66.83 | 8.74 |
Net Current Asset Value |
111.30 | 148.32 | 90.99 | (187.19) | 54.57 | 66.75 | 8.52 |
EV/EBIT |
— | — | 1.27 | — | — | — | — |
Capex to Sales |
— | — | 0.00 | — | — | — | — |
Price to Operating Income |
— | — | 0.00 | — | — | — | — |
| Other line items | |||||||
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.39 | 0.64 | 0.28 |
Cash ROIC |
(20.33%) | (13.82%) | (12.78%) | 15.84% | (19.14%) | (7.67%) | (54.34%) |
Accounts Receivable Turnover |
— | — | 0.00 | — | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
1.37 | 0.81 | 0.66 | — | — | — | — |
Average Assets |
138.37 | 128.49 | 64.88 | 46.03 | 64.00 | 40.06 | — |
Average Common Equity |
133.59 | 123.44 | (47.94) | (172.60) | (147.08) | (130.61) | — |
Columns are period end dates